SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-10-135873
Filing Date
2010-06-09
Accepted
2010-06-09 14:55:38
Documents
2
Group Members
ASTELLAS US HOLDING, INC.RUBY ACQUISITION, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.htm SC 13D 111612
2 POWER OF ATTORNEY DATED JUNE 2, 2010 dex994.htm EX-99.4 5673
  Complete submission text file 0001193125-10-135873.txt   119308
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-37954 | Film No.: 10887042
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC 13D